PL434485A1 - Synergistyczna kompozycja fagów oraz sposób jej otrzymywania - Google Patents
Synergistyczna kompozycja fagów oraz sposób jej otrzymywaniaInfo
- Publication number
- PL434485A1 PL434485A1 PL434485A PL43448520A PL434485A1 PL 434485 A1 PL434485 A1 PL 434485A1 PL 434485 A PL434485 A PL 434485A PL 43448520 A PL43448520 A PL 43448520A PL 434485 A1 PL434485 A1 PL 434485A1
- Authority
- PL
- Poland
- Prior art keywords
- bactericidal activity
- composition
- obtaining
- synergistic
- phages
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 7
- 230000002195 synergetic effect Effects 0.000 title abstract 3
- 230000000844 anti-bacterial effect Effects 0.000 abstract 6
- UXUFTKZYJYGMGO-CMCWBKRRSA-N (2s,3s,4r,5r)-5-[6-amino-2-[2-[4-[3-(2-aminoethylamino)-3-oxopropyl]phenyl]ethylamino]purin-9-yl]-n-ethyl-3,4-dihydroxyoxolane-2-carboxamide Chemical group O[C@@H]1[C@H](O)[C@@H](C(=O)NCC)O[C@H]1N1C2=NC(NCCC=3C=CC(CCC(=O)NCCN)=CC=3)=NC(N)=C2N=C1 UXUFTKZYJYGMGO-CMCWBKRRSA-N 0.000 abstract 2
- 230000001580 bacterial effect Effects 0.000 abstract 2
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 241001515965 unidentified phage Species 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/00021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/00032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/00051—Methods of production or purification of viral material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Przedmiotem zgłoszenia jest sposób otrzymywania synergistycznej kompozycji fagów, charakteryzujący się tym, że uzyskuje się co najmniej dwa różne szczepy fagowe specyficzne wobec tego samego szczepu bakterii, określa się aktywność bakteriobójczą każdego ze szczepów fagów osobno oraz aktywność bakteriobójczą ich mieszaniny wobec tego szczepu bakterii, porównuje się aktywność bakteriobójczą określoną dla każdego ze szczepów fagów stosowanych osobno z aktywnością bakteriobójczą określoną dla ich mieszaniny i w przypadku stwierdzenia, że aktywność bakteriobójcza mieszaniny jest wyższa od aktywności bakteriobójczej każdego z fagów stosowanych osobno uznaje się, że fagi te tworzą kompozycję energistyczną. Przedmiotem zgłoszenia jest również synergistyczna kompozycja fagów specyficznych wobec bakterii APEC oraz wybrany szczep bakteriofaga nadający się do zapobiegania lub zwalczania zakażeń szczepami APEC.
Priority Applications (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL434485A PL434485A1 (pl) | 2020-06-26 | 2020-06-26 | Synergistyczna kompozycja fagów oraz sposób jej otrzymywania |
| BR112022026489A BR112022026489A2 (pt) | 2020-06-26 | 2021-06-28 | Composição sinergística de fagos e seu método de formação |
| IL299434A IL299434A (en) | 2020-06-26 | 2021-06-28 | A synergistic preparation of phages and a method for its creation |
| KR1020237002238A KR20230038491A (ko) | 2020-06-26 | 2021-06-28 | 파지의 상승적 조성물 및 이의 형성 방법 |
| MX2023000208A MX2023000208A (es) | 2020-06-26 | 2021-06-28 | Composicion sinergica de fagos y su metodo de formacion. |
| PCT/PL2021/050047 WO2021262019A1 (en) | 2020-06-26 | 2021-06-28 | Synergistic composition of phages and its formation method |
| CA3183521A CA3183521A1 (en) | 2020-06-26 | 2021-06-28 | Synergistic composition of phages and its formation method |
| EP21762150.7A EP4171597A1 (en) | 2020-06-26 | 2021-06-28 | Synergistic composition of phages and its formation method |
| US18/012,318 US20240050498A1 (en) | 2020-06-26 | 2021-06-28 | Synergistic composition of phages and its formation method |
| CN202180052662.1A CN116096868A (zh) | 2020-06-26 | 2021-06-28 | 噬菌体的协同组合物及其形成方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL434485A PL434485A1 (pl) | 2020-06-26 | 2020-06-26 | Synergistyczna kompozycja fagów oraz sposób jej otrzymywania |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL434485A1 true PL434485A1 (pl) | 2021-12-27 |
Family
ID=77519726
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL434485A PL434485A1 (pl) | 2020-06-26 | 2020-06-26 | Synergistyczna kompozycja fagów oraz sposób jej otrzymywania |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240050498A1 (pl) |
| EP (1) | EP4171597A1 (pl) |
| KR (1) | KR20230038491A (pl) |
| CN (1) | CN116096868A (pl) |
| BR (1) | BR112022026489A2 (pl) |
| CA (1) | CA3183521A1 (pl) |
| IL (1) | IL299434A (pl) |
| MX (1) | MX2023000208A (pl) |
| PL (1) | PL434485A1 (pl) |
| WO (1) | WO2021262019A1 (pl) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3253215B1 (en) * | 2015-01-23 | 2023-06-14 | Intralytix, Inc. | Novel shigella bacteriophages and uses thereof |
| US10357522B2 (en) * | 2016-06-22 | 2019-07-23 | The United States Of America As Represented By The Secretary Of The Navy | Bacteriophage compositions and methods of selection of components against specific bacteria |
| DK3548053T3 (da) * | 2016-12-05 | 2022-05-09 | Technophage Investig E Desenvolvimento Em Biotecnologia Sa | Bakteriofagsammensætninger, der omfatter respiratoriske antibakterielle fager, og fremgangsmåder til anvendelse deraf |
-
2020
- 2020-06-26 PL PL434485A patent/PL434485A1/pl unknown
-
2021
- 2021-06-28 CN CN202180052662.1A patent/CN116096868A/zh active Pending
- 2021-06-28 US US18/012,318 patent/US20240050498A1/en active Pending
- 2021-06-28 KR KR1020237002238A patent/KR20230038491A/ko active Search and Examination
- 2021-06-28 EP EP21762150.7A patent/EP4171597A1/en active Pending
- 2021-06-28 IL IL299434A patent/IL299434A/en unknown
- 2021-06-28 CA CA3183521A patent/CA3183521A1/en active Pending
- 2021-06-28 BR BR112022026489A patent/BR112022026489A2/pt unknown
- 2021-06-28 MX MX2023000208A patent/MX2023000208A/es unknown
- 2021-06-28 WO PCT/PL2021/050047 patent/WO2021262019A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112022026489A2 (pt) | 2023-05-09 |
| CA3183521A1 (en) | 2021-12-30 |
| US20240050498A1 (en) | 2024-02-15 |
| CN116096868A (zh) | 2023-05-09 |
| WO2021262019A1 (en) | 2021-12-30 |
| MX2023000208A (es) | 2023-02-09 |
| KR20230038491A (ko) | 2023-03-20 |
| EP4171597A1 (en) | 2023-05-03 |
| IL299434A (en) | 2023-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021014441A (es) | Inhibidores del dominio asociado mejorador de la transcripcion (tead) y usos de los mismos. | |
| MX2021014443A (es) | Inhibidores del dominio asociado mejorador de la transcripcion (tead) y usos de los mismos. | |
| MX2020007797A (es) | Inhibidores de la cinasa 2 de control general no desrepresible (gcn2) y usos de los mismos. | |
| MX2022015272A (es) | Inhibidores de la proteina kras g12c y usos de estos. | |
| PH12021550187A1 (en) | Pyrrolopyrimidine itk inhibitors | |
| MX2010001666A (es) | Composiciones y metodos para el tratamiento de semillas. | |
| SG11202112872YA (en) | Substituted 1-oxo-isoindoline-5-carboxamide compounds, compositions thereof, and methods of treatment therewith | |
| MX2021000093A (es) | Antagonistas del receptor de tipo toll 7/8 (tlr7/8) y usos de los mismos. | |
| MX2021012501A (es) | Inhibidores de complejo represivo polycomb 2 (prc2). | |
| ZA202102702B (en) | Synergistic disinfectant compositions having enhanced antimicrobial efficacy and stability, and methods of using the same | |
| GB202108194D0 (en) | Bacteriophage composition, bacteriostat, and use thereof | |
| MX2022003037A (es) | Compuestos antibacterianos. | |
| MX2021001471A (es) | Benzimidazoles sustituidos como inhibidores de peptidil arginina deiminasa 4 (pad4). | |
| MY191930A (en) | Microbial lysozyme for use in the treatment of irritable bowel syndrome or inflammatory bowel disease | |
| MX2021000719A (es) | Composicion de microbiota fecal, para su uso en la reduccion de la inflamacion inducida por tratamiento. | |
| PL434485A1 (pl) | Synergistyczna kompozycja fagów oraz sposób jej otrzymywania | |
| ZA202202507B (en) | Nitrification inhibitors | |
| PH12021550121A1 (en) | Methods of treating hfpef employing dapagliflozin and compositions comprising the same | |
| PH12020551100A1 (en) | Bowel cleansing composition | |
| MX2017012539A (es) | Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas. | |
| MX2020011853A (es) | Composiciones prebioticas y metodos para mantener una microbiota cutanea saludable. | |
| IL299751A (en) | Preparations and methods for disinfection, treatment and prevention of bacterial infections | |
| MX2022003814A (es) | Compuestos antibacterianos de 4-quinolinona. | |
| MX2022003816A (es) | Compuestos antibacterianos. | |
| MX2021007115A (es) | Composicion que comprende raiz de achicoria y fibra de la pared celular de chicharo para tratar infecciones por brachyspira. |